$RVMD
Revolution Medicines, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is RVMD up today? It is at $199.19 (+0.96%), and our scanner flagged it 79 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RVMD spikes, and full due diligence on RVMD — key stats, earnings, dilution and insider activity. Free.
Get free $RVMD alerts the moment volume spikes
Our scanner flagged $RVMD 79 times in the last 30 days. Create a free account to track $RVMD, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $199.19
- Change today
- +0.96%
- Previous close
- $197.30
- 52-week range
- $34.00 – $198.29
- Market cap
- $41.95B
- Total held
- 5.3%
- Tradeable float
- 202.9M 95% of shares · after 5% insiders + institutional n/a
- Short interest
- 14.0M ▲ +9% vs prior · as of 2026-07-15
- Short % of float
- 6.9%
- Days to cover
- 6.8d
- Avg daily volume
- 2.8M
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5m
- 0.1x
- 15m
- 0.2x
- 1h
- 1.2x
- 1D
- 0.1x
Get free RVMD + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $RVMD up today?
Here is the latest on RVMD from our scanner (live price and day move above). Fresh from the SEC: Revolution Medicines, Inc. filed a Quarterly report (10-Q). A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystQuarterly report (10-Q), from the latest SEC filing. Read it →Dilution watch
Recent offeringAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $RVMD runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- At-the-market (ATM) program — sells new shares into the market gradually over time · Priced at $142.00/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$RVMD Sentiment
NeutralBlend of news sentiment, today’s move, and community votes. Not investment advice.
$RVMD Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
Stocks similar to RVMD
Comparable names in biological products, (no diagnostic substances), closest in size first.
RVMD stock FAQ
Why is $RVMD up today?
Here is the latest on RVMD from our scanner (live price and day move above). Fresh from the SEC: Revolution Medicines, Inc. filed a Quarterly report (10-Q). A material company disclosure like this is often the real catalyst behind a move of this size.
What is the RVMD stock price today?
RVMD last traded at $199.19, up 0.96% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live RVMD alerts?
The RVMD Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RVMD 79 times in the last 30 days.
What exchange is RVMD on?
RVMD (Revolution Medicines, Inc. Common Stock) trades on XNAS, with a market cap of about $41.95B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is RVMD good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RVMD for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.